Clinical trial
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3
NCT00000331 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- December 31, 2002
- Completion date
- December 31, 2002
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.